Nexalin Technology (NXL) Depreciation & Amortization (CF) (2021 - 2026)
Nexalin Technology's (NXL) quarterly Depreciation & Amortization (CF) came in at $4106.0 in Q1 2026, up 3965.35% quarter-over-quarter from $101.0 in Q4 2023.
Nexalin Technology (NXL) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Nexalin Technology's Depreciation & Amortization (CF) history runs 4 years deep, the most recent figure standing at $4106.0 for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) changed N/A year-over-year to $4106.0 in Q1 2026; TTM through Mar 2026 was $4106.0, a N/A change from a year earlier, with the FY2023 full-year figure at $503.0, down 5.98% from the prior year.
- Depreciation & Amortization (CF) advanced to $4106.0 in Q1 2026 per NXL's latest filing, from $101.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $4106.0 in Q1 2026 and bottomed at $101.0 in Q4 2023.
- The 3-year median for Depreciation & Amortization (CF) is $134.0 (2022), against an average of $571.56.
- Biggest YoY gain for Depreciation & Amortization (CF) was 0.0% in 2023; the steepest drop was 23.48% in 2023.
- Year by year, Depreciation & Amortization (CF) stood at $132.0 in 2022, then retreated by 23.48% to $101.0 in 2023, then jumped by 3965.35% to $4106.0 in 2026.
- Per Business Quant, the three latest NXL Depreciation & Amortization (CF) figures stand at $4106.0 (Q1 2026), $101.0 (Q4 2023), and $134.0 (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn | 67.10 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 78.00 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn | 310.25 Mn |
| 10 | Nexalin Technology | 9.43 Mn | 6.72 Mn | 13,133.00 | 4,106.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,106.00 |
| Mar 31, 2026 | 4,106.00 |
| Dec 31, 2023 | 101.00 |
| Dec 31, 2023 | 101.00 |
| Sep 30, 2023 | 134.00 |
| Sep 30, 2023 | 134.00 |
| Jun 30, 2023 | 134.00 |
| Jun 30, 2023 | 134.00 |
| Mar 31, 2023 | 134.00 |
| Mar 31, 2023 | 134.00 |
| Dec 31, 2022 | 132.00 |
| Dec 31, 2022 | 132.00 |
| Sep 30, 2022 | 135.00 |
| Sep 30, 2022 | 135.00 |
| Jun 30, 2022 | 134.00 |
| Jun 30, 2022 | 134.00 |
| Mar 31, 2022 | 134.00 |
| Mar 31, 2022 | 134.00 |
| Dec 31, 2021 | 134.00 |
| Dec 31, 2021 | 134.00 |